Madrigal Pharmaceuticals, Inc.
MDGL
Revenue
62.18M
▲47.54M▲324.75%
3 Months ChangeAssets
1.07B
▼-26.52M▼-2.41%
3 Months ChangeLiabilities
296.11M
▲53.44M▲22.02%
3 Months ChangeFree Cash Flow
-149.51M
▼-65.41M▼-77.78%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0001628280-24-044445
2024-10-31
Form 8-K
ID: 0001193125-24-248137
2024-08-07
Form 10-Q
ID: 0001628280-24-035400
2024-08-07
Form 8-K
ID: 0001193125-24-195400
2024-06-27
Form 8-K
ID: 0001193125-24-170634
2024-05-07
Form 8-K
ID: 0001193125-24-133196
2024-05-07
Form 10-Q
ID: 0001628280-24-020865
2024-05-07
Form 8-K
ID: 0001193125-24-132559
2024-04-02
Form 8-K
ID: 0001193125-24-084797
2024-03-20
Form 8-K
ID: 0001193125-24-072706